Factors associated with transition readiness among perinatally infected adolescents living with HIV in rural southwestern Uganda.

International Workshop on HIV & Adolescence 2021

Effectiveness of enrolment into Orphan and Vulnerable Children program in achieving viral suppression amongst pediatrics and adolescents in Benue State, Nigeria.

International Workshop on HIV & Adolescence 2021

“It’s already in your body and it’s preventing”:  A Qualitative Study of African Female Adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa

International Workshop on HIV & Adolescence 2021

Making up for Lost Time: Increasing Access to PrEP and HIV Self-testing for Key Populations in Malawi

International Workshop on HIV & Adolescence 2021

How many adolescents do we actually lose along the HIV treatment cascade?: Accounting for aging up in adolescent continuity of treatment

International Workshop on HIV & Adolescence 2021

Predictors of viral load suppression among HIV positive pediatrics, adolescents & young people in Alimosho LGA, Lagos Nigeria

International Workshop on HIV & Adolescence 2021

Calculus of Sex – Lessons Learnt

International Workshop on HIV & Adolescence 2021

Lessons learned from a longitudinal cohort study of children who acquired HIV perinatally in Cape Town, South Africa

International Workshop on HIV & Adolescence 2021

Mental Health intervention to improve uptake of HIV treatment among young sex workers: A case study of Bar Hostess Empowerment and Support Program (BHESP)

International Workshop on HIV & Adolescence 2021

“I had to always think positive” - resilience measures adopted by young people to navigate COVID-19

International Workshop on HIV & Adolescence 2021

On the CATS Lounge: Insights from a digital peer support innovation co-designed with and for adolescent peer mentors in Zimbabwe.

International Workshop on HIV & Adolescence 2021

“I feel like it is asking if he is a stalker… But I also feel like it is asking if he cares”: Exploring South African Youth’s Perceptions of the Sexual Relationship Power Scale

International Workshop on HIV & Adolescence 2021

Effective Methods In Identifying New HIV Infection Rate among Adolescent Key Population in Lagos-State, Nigeria.

International Workshop on HIV & Adolescence 2021

Strong Bodies, Strong Minds: Qualitative baseline for an integrated sport-based SRHR and mental health program for YLHIV

International Workshop on HIV & Adolescence 2021

Young lives in lockdown: Lessons of resilience and responsibility from young people’s stories and images documented during the COVID-19 lockdown in Kenya.

International Workshop on HIV & Adolescence 2021

The need for integrated, age group and gender dis-aggregated data in DHIS 2 to inform policies on adolescent girls and young women (AGYW) in Malawi.

International Workshop on HIV & Adolescence 2021

Caregiver HIV Status Disclosure associated risk of distress, anxiety and depressive symptoms in dependent 8 – 18 years old children from Uganda

International Workshop on HIV & Adolescence 2021

Virological Failures and Genotypic Resistance in Children and Adolescents Randomised to Dolutegravir-Based ART vs. Standard-of-Care in the ODYSSEY Trial

International Workshop on HIV Pediatrics 2021

Early Infant Diagnosis of HIV and Linkage to Antiretroviral Therapy in the Context of COVID-19 in Fifteen Sub-Saharan African Countries

International Workshop on HIV Pediatrics 2021

Pediatric and Adolescent HIV Viral Load Coverage and Suppression Rates in the Context of the COVID-19 Pandemic in 14 Sub-Saharan African PEPFAR Countries in 2019 and 2020

International Workshop on HIV Pediatrics 2021

Efficacy, Safety and Tolerability of Guideline-Recommended ARVs from Pediatric Clinical Trials: A Systematic Review

International Workshop on HIV Pediatrics 2021

Once-Daily Integrase Inhibitor (Insti) With Boosted Darunavir is Non-Inferior to Standard of Care in Virogically Suppressed Children, Week 48 Results of the Smile PENTA-17 Trial

International Workshop on HIV Pediatrics 2021

B/F/Taf in Virologically Suppressed Adolescents and Children: Two-Year Outcomes in 6 to <18 Year Olds And Six-Month Outcomes in Toddlers

International Workshop on HIV Pediatrics 2021

Long-term Safety & Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Fumarate (E/C/F/TAF) Single-Tablet Regimen in in Children and Adolescents Living with HIV

International Workshop on HIV Pediatrics 2021